Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab

By Al-Mutairi Nawaf   Nour Tarek   Al-Rqobah Duha  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 625-629

Informa Healthcare

Access to resources Recommend Favorite

Novel biologic therapies for psoriasis

By Barry Jane   Kirby Brian  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 6, 2004-06 ,pp. : 975-987

Informa Healthcare

Access to resources Recommend Favorite

The role of biologic agents in the management of non-infectious uveitis

By Heo Jangwon   Sepah Yasir J   Yohannan Jithin   Renner Morgan   Akhtar Abeer   Gregory Anthony   Shulman Mathew   Do Diana V   Nguyen Quan Dong  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 995-1008

Informa Healthcare

Access to resources Recommend Favorite

TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis

By Saraceno Rosita   Pietroleonardo Lucia   Mazzotta Annamaria   Zangrilli Arianna   Bianchi Luca   Chimenti Sergio  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 469-473

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis

By Uhlenhake Elizabeth E   Feldman Steven R  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1105-1112

Informa Healthcare

Access to resources Recommend Favorite